• Telix appointed three non-executive directors, effective May 11, 2026: David Gill, Maria Rivas, MD, William Jellison.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telix Pharmaceuticals Ltd. published the original content used to generate this news brief on July 21, 2026, and is solely responsible for the information contained therein.